“Novel In-Office Injectables for the Dermatology–Rheumatology Patient: Botulinum Toxin, Sodium Thiosulfate, and Hyaluronidase”. Canadian Dermatology Today, vol. 7, no. 3, Sept. 2026, pp. 4-10, https://doi.org/10.58931/cdt.2026.73167.